Key result
A multidisciplinary approach involving a left ventricular assist device, ECMO, IVIG, and peramivir successfully treated a patient with H1N1 fulminant myocarditis and cardiogenic shock.
Case Report (n=1)
Demonstrates the successful use of mechanical circulatory support and targeted medical therapy in managing fulminant H1N1 myocarditis with refractory cardiogenic shock.
Supports feasibility of multidisciplinary rescue in H1N1 fulminant myocarditis; hypothesis-generating and should not yet change practice.
The outbreak and spread of the new influenza A subtype H1N1 reached pandemic levels during 2009, with greater numbers of cases reported daily and numerous complications described. The present report concerns an atypical manifestation of the disease in a previously healthy middle-aged patient who presented with severe, refractory cardiogenic shock 4 days after being diagnosed as having influenza A. The patient was considered for emergency heart transplant. Successful treatment involved the use of a left ventricular assist device, extracorporeal membrane oxygenation, intravenous immunoglobulin and peramivir as therapeutics and bridging therapies for transplant. This case is a report of H1N1 fulminant myocarditis and illustrates the usefulness of a multidisciplinary approach in the care of these patients.
No takes yet. Share an insight, caveat, or question.
Cobas et al. (2010) conducted a case report in Fulminant influenza A subtype H1N1 myocarditis (n=1). Left ventricular assist device, extracorporeal membrane oxygenation, intravenous immunoglobulin and peramivir was evaluated on Successful treatment/survival. A multidisciplinary approach involving a left ventricular assist device, ECMO, IVIG, and peramivir successfully treated a patient with H1N1 fulminant myocarditis and cardiogenic shock.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: